The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
HLA class I-restricted lysis of leukemia cells by a CD8+ cytotoxic T-lymphocyte clone specific for WT1 peptide
Abstract
The Wilms tumor (WT1) gene has been reported to be preferentially expressed in acute leukemia cells, regardless of leukemia subtype and chronic myelogenous leukemia cells in blast crisis, but not in normal cells. This finding suggests strongly that WT1 protein is a potential target of immunotherapy for human leukemia. In this study, we established a CD8+ cytotoxic T-lymphocyte (CTL) clone directed against a WT1-derived peptide and examined its immunologic actions on leukemia cells. A CD8+ CTL clone, designated TAK-1, which lysed autologous cells loaded with a WT1-derived 9-mer peptide consisting of the HLA-A24 (HLA-A*2402)-binding motifs was established by stimulating CD8+ T lymphocytes from a healthy individual repeatedly with WT1 peptide-pulsed autologous dendritic cells. TAK-1 was cytotoxic to HLA-A24–positive leukemia cells expressing WT1, but not to HLA-A24–positive lymphoma cells that did not express WT1, HLA-A24–negative leukemia cells, or HLA-A24–positive normal cells. Treating leukemia cells with an antisense oligonucleotide complementary to the WT1 gene resulted in reduced TAK-1-mediated cytotoxicity, suggesting that target antigen of TAK-1 on leukemia cells is the naturally processed WT1 peptide in the context of HLA-A24. TAK-1 did not inhibit colony formation by normal bone marrow cells of HLA-A24–positive individuals. Because WT1 is overexpressed ubiquitously in various types of leukemia cells, but not in normal cells, immunotherapy using WT1 peptide-specific CTL clones should be an efficacious treatment for human leukemia. (Blood. 2000;95:286-293)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
WT-1 is required for early kidney development
Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., & Jaenisch, R. (1993) · Cell · doi:10.1016/0092-8674(93)90515-r · Cited by 1,989
Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Kral, A., Yeger, H., Lewis, W. H., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90601-a · Cited by 1,876
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
The candidate Wilms' tumour gene is involved in genitourinary development
Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., et al. (1990) · Nature · doi:10.1038/346194a0 · Cited by 864
Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., & Nasu, K. (1994) · Blood · doi:10.1182/blood.v84.9.3071.3071 · Cited by 575
Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Expression of the Wilms' tumor gene WT1 in the murine urogenital system.
Pelletier, J., Schalling, M., Buckler, A. J., Rogers, A., Haber, D. A., & Housman, D. (1991) · Genes & Development · doi:10.1101/gad.5.8.1345 · Cited by 439
Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia
Inoue, K., Ogawa, H., Sonoda, Y., Kimura, T., Sakabe, H., Oka, Y., Miyake, S., Tamaki, H., Oji, Y., Yamagami, T., et al. (1997) · Blood · doi:10.1182/blood.v89.4.1405 · Cited by 371
Bergmann, L., Miething, C., Maurer, U., Brieger, J., Karakas, T., Weidmann, E., & Hoelzer, D. (1997) · Blood · doi:10.1182/blood.v90.3.1217 · Cited by 354
Expression of the Wilms' tumor gene (WT1) in human leukemias.
Miwa, H., Beran, M., & Saunders, G. F. (1992) · PubMed · Cited by 349
Molldrem, J., Dermime, S., Parker, K., Jiang, Y., Mavroudis, D., Hensel, N., Fukushima, P., & Barrett, A. (1996) · Blood · doi:10.1182/blood.v88.7.2450.bloodjournal8872450 · Cited by 325
Menssen, H. D., Renkl, H., Rodeck, U., Maurer, J., Notter, M., Schwartz, S., Reinhardt, R., & Thiel, E. (1995) · PubMed · Cited by 299
Choudhury, A., Gajewski, J. L., Liang, J. C., Popat, U., Claxton, D. F., Kliche, K.-O., Andreeff, M., & Champlin, R. E. (1997) · Blood · doi:10.1182/blood.v89.4.1133 · Cited by 285
A new leukemia cell line with philadelphia chromosome characterized as basophil precursors
Kishi, K. (1985) · Leukemia Research · doi:10.1016/0145-2126(85)90060-8 · Cited by 256
Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, T., Hirata, M., Kudoh, T., Akiyama, T., Murakami, A., & Maekawa, T. (1996) · Blood · doi:10.1182/blood.v87.7.2878.bloodjournal8772878 · Cited by 251
III, F. J. R. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.10.8393820 · Cited by 248
Choudhury, A., Liang, J. C., Thomas, E. K., Flores-Romo, L., Xie, Q. S., Agusala, K., Sutaria, S., Sinha, I., Champlin, R. E., & Claxton, D. F. (1999) · Blood · doi:10.1182/blood.v93.3.780 · Cited by 239
Yotnda, P., Firat, H., Garcia-Pons, F., Garcia, Z., Gourru, G., Vernant, J. P., Lemonnier, F. A., Leblond, V, & Langlade-Demoyen, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci488 · Cited by 238
Molldrem, J. J., Clave, E., Jiang, Y. Z., Mavroudis, D., Raptis, A., Hensel, N., Agarwala, V., & Barrett, A. J. (1997) · Blood · doi:10.1182/blood.v90.7.2529 · Cited by 234
Park, S., Schalling, M., Bernard, A., Maheswaran, S., Shipley, G. C., Roberts, D., Fletcher, J., Shipman, R., Rheinwald, J., Demetri, G., et al. (1993) · Nature Genetics · doi:10.1038/ng0893-415 · Cited by 206
Amin, K. M., Litzky, L. A., Smythe, W. R., et al. (1995) · PubMed · Cited by 199
Inoue, K., Ogawa, H., Yamagami, T., Soma, T., Tani, Y., Tatekawa, T., Oji, Y., Tamaki, H., Kyo, T., Dohy, H., et al. (1996) · Blood · doi:10.1182/blood.v88.6.2267.bloodjournal8862267 · Cited by 183
Tokunaga, K., Ishikawa, Y., Ogawa, A., Wang, H., Mitsunaga, S., Moriyama, S., Lin, L., Bannai, M., Watanabe, Y., Kashiwase, K., et al. (1997) · Immunogenetics · doi:10.1007/s002510050262 · Cited by 180
Tissue, Developmental, and Tumor-Specific Expression of Divergent Transcripts in Wilms Tumor
Huang, A., Campbell, C. E., Bonetta, L., McAndrews-Hill, M. S., Chilton-MacNeill, S., Coppes, M. J., Law, D. J., Feinberg, A. P., Yeger, H., & Williams, B. R. G. (1990) · Science · doi:10.1126/science.2173145 · Cited by 158
Gambacorti-Passerini, C. B., Grignani, F., Arienti, F., Pandolfi, P. P., Pelicci, P. G., & Parmiani, G. (1993) · Blood · doi:10.1182/blood.v81.5.1369.1369 · Cited by 140
Nieda, M., Nicol, A. J., Kikuchi, A., Kashiwase, K., Taylor, K., Suzuki, K., Tadokoro, K., & Juji, T. (1998) · Blood · doi:10.1182/blood.v91.3.977 · Cited by 129
DNA typing of the HLA‐A gene: population study and identification of four new alleles in Japanese
Date, Y., Kimura, A., Kato, H., & Sasazuki, T. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02520.x · Cited by 126
Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia
Schmid, D., Heinze, G., Linnerth, B., Tisljar, K., Kušec, R., Geissler, K. H., Sillaber, C., Laczika, K. F., Mitterbauer, M., Zöchbauer‐Müller, S., et al. (1997) · Leukemia · doi:10.1038/sj.leu.2400620 · Cited by 124
Yotnda, P., Garcia, F., Peuchmaur, M. M., Grandchamp, B., Duval, M., Lemonnier, F. A., VILMER, E., & Langlade‐Demoyen, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3126 · Cited by 111
Mannering, S. I., McKenzie, J. L., Fearnley, D. B., & Hart, D. N. J. (1997) · Blood · doi:10.1182/blood.v90.1.290 · Cited by 106
Eibl, B., Ebner, S., Duba, C., Böck, G., Romani, N., Erdel, M., Gächter, A., Niederwieser, D. W., & Schuler, G. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199711)20:3<215::aid-gcc1>3.0.co;2-5 · Cited by 97
Osman, Y., Takahashi, M., Zheng, Z., Koike, T., Toba, K., Liu, A., Furukawa, T., Aoki, S., & Aizawa, Y. (1999) · Leukemia · doi:10.1038/sj.leu.2401311 · Cited by 88
Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules
Kondo, A., Sidney, J., Southwood, S., del Guercio, M. F., Appella, E., Sakamoto, H., Celis, E., Grey, H. M., Chesnut, R. W., Kubo, R. T., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4307 · Cited by 85
Cytotoxic T‐lymphocyte (CTL) responses against acute or chronic myeloid leukemia
Falkenburg, J. H. F., Smit, W. M., & Willemze, R. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00985.x · Cited by 71
HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies
Karaki, S., Kariyone, A., Kato, N., Kano, K., Iwakura, Y., & Takiguchi, M. (1993) · Immunogenetics · doi:10.1007/bf00216838 · Cited by 45
Ohminami, H., Yasukawa, M., Kaneko, S., Yakushijin, Y., Abe, Y., Kasahara, Y., Ishida, Y., & Fujita, S. (1999) · Blood · doi:10.1182/blood.v93.3.925 · Cited by 44
Self-citationMolecular mechanisms possibly affecting WT1 function in human ovarian tumors
Viel, A., Giannini, F., Capozzi, E., Canzonieri, V., Scarabelli, C., Gloghini, A., & Boiocchi, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570413 · Cited by 37
Cited by
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
A listing of human tumor antigens recognized by T cells
Renkvist, N., Castelli, C., Robbins, P. F., & Parmiani, G. (2001) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620000169 · Cited by 694
Tumor neoantigens: building a framework for personalized cancer immunotherapy
Gubin, M. M., Artyomov, M. N., Mardis, E. R., & Schreiber, R. D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80008 · Cited by 613
Oka, Y., Tsuboi, A., Taguchi, T., Osaki, T., Kyo, T., Nakajima, H., Elisseeva, O. A., Oji, Y., Kawakami, M., Ikegame, K., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405884101 · Cited by 531
A listing of human tumor antigens recognized by T cells: March 2004 update
Novellino, L., Castelli, C., & Parmiani, G. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0560-6 · Cited by 466
Metadata
- Authors
- Ohminami, H., Yasukawa, M., & Fujita, S.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2000-01-01
- Volume
- 95
- Issue
- 1
- Pages
- 286-293
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W204705285
- Cited by
- 347
- References
- 38
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.